Approximately 60% of the NUTM2A-AS1::RP11–203L2.4 containing tumor cells were solely identified by long read evidence, another 20% by short reads only, and the remaining 20% by both short and long reads (Figure 5b). This evidence concerns the gene NUTM2A and neoplasm.